Factors affecting long-term efficacy of T regulatory cell-based therapy in type 1 diabetes

Background Recent studies suggest that immunotherapy using T regulatory cells (Tregs) prolongs remission in type 1 diabetes (T1DM). Here, we report factors that possibly affect the efficacy of this treatment.